Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.

Hinkula J, Devignot S, Åkerström S, Karlberg H, Wattrang E, Bereczky S, Mousavi-Jazi M, Risinger C, Lindegren G, Vernersson C, Paweska J, van Vuren PJ, Blixt O, Brun A, Weber F, Mirazimi A.

J Virol. 2017 Apr 28;91(10). pii: e02076-16. doi: 10.1128/JVI.02076-16. Print 2017 May 15.

2.

Level of Oxidative Stress Markers in Peri-Implant Crevicular Fluid and Their Correlation with Clinical Parameters.

Mousavi Jazi M, Sadeghi Pour Rodsari HR, Mirmiran F.

J Dent (Tehran). 2015 May;12(5):340-6.

3.

Molecular and serological findings in suspected patients with Crimean-Congo hemorrhagic fever virus in Iran.

Karlberg H, Sharifi-Mood B, Mousavi-Jazi M, Dilcher M, Lindegren G, Mardani M, Bereskly S, Weidmann M, Mirazimi A.

J Med Virol. 2015 Apr;87(4):686-93. doi: 10.1002/jmv.24106. Epub 2015 Feb 3.

PMID:
25649667
4.

Application of an Acellular Dermal Matrix Allograft (CenoDerm) for Treatment of Multiple Gingival Recession Defects: A Case Report with One-year Follow-up.

Moslemi N, Heidari M, Mousavi Jazi M, Daneshmonfared M.

J Dent Res Dent Clin Dent Prospects. 2014 Summer;8(3):180-3. doi: 10.5681/joddd.2014.033. Epub 2014 Sep 17.

5.

Crimean-Congo hemorrhagic fever virus, Greece.

Papa A, Sidira P, Larichev V, Gavrilova L, Kuzmina K, Mousavi-Jazi M, Mirazimi A, Ströher U, Nichol S.

Emerg Infect Dis. 2014 Feb;20(2):288-90. doi: 10.3201/eid2002.130690.

6.

Healthy individuals' immune response to the Bulgarian Crimean-Congo hemorrhagic fever virus vaccine.

Mousavi-Jazi M, Karlberg H, Papa A, Christova I, Mirazimi A.

Vaccine. 2012 Sep 28;30(44):6225-9. doi: 10.1016/j.vaccine.2012.08.003. Epub 2012 Aug 14.

PMID:
22902680
7.

Acellular dermal matrix allograft versus subepithelial connective tissue graft in treatment of gingival recessions: a 5-year randomized clinical study.

Moslemi N, Mousavi Jazi M, Haghighati F, Morovati SP, Jamali R.

J Clin Periodontol. 2011 Dec;38(12):1122-9. doi: 10.1111/j.1600-051X.2011.01789.x. Epub 2011 Oct 2.

PMID:
22092784
8.

Effects of Angipars on oxidative inflammatory indices in a murine model of periodontitis.

Mousavi-Jazi M, Aslroosta H, Moayer AR, Baeeri M, Abdollahi M.

Daru. 2010;18(4):260-4.

9.

Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response.

Andersson I, Karlberg H, Mousavi-Jazi M, Martínez-Sobrido L, Weber F, Mirazimi A.

J Med Virol. 2008 Aug;80(8):1397-404. doi: 10.1002/jmv.21222.

PMID:
18551619
10.

Spontaneous mutations in the human CMV HLA class I homologue UL18 affect its binding to the inhibitory receptor LIR-1/ILT2/CD85j.

Cerboni C, Achour A, Wärnmark A, Mousavi-Jazi M, Sandalova T, Hsu ML, Cosman D, Kärre K, Carbone E.

Eur J Immunol. 2006 Mar;36(3):732-41.

11.

LightUp probes in clinical diagnostics.

Leijon M, Mousavi-Jazi M, Kubista M.

Mol Aspects Med. 2006 Apr-Jun;27(2-3):160-75. Epub 2006 Feb 8. Review.

PMID:
16466783
12.

Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus.

Akerström S, Mousavi-Jazi M, Klingström J, Leijon M, Lundkvist A, Mirazimi A.

J Virol. 2005 Feb;79(3):1966-9.

13.

Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus.

Andersson I, Bladh L, Mousavi-Jazi M, Magnusson KE, Lundkvist A, Haller O, Mirazimi A.

J Virol. 2004 Apr;78(8):4323-9.

14.

Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.

Rölle A, Mousavi-Jazi M, Eriksson M, Odeberg J, Söderberg-Nauclér C, Cosman D, Kärre K, Cerboni C.

J Immunol. 2003 Jul 15;171(2):902-8.

15.

Point mutations induced by foscarnet (PFA) in the human cytomegalovirus DNA polymerase.

Mousavi-Jazi M, Schloss L, Wahren B, Brytting M.

J Clin Virol. 2003 Apr;26(3):301-6.

PMID:
12637079
16.

A case of diffuse leptomeningeal oligodendrogliomatosis associated with HHV-6 variant A.

Stödberg T, Deniz Y, Esteitie N, Jacobsson B, Mousavi-Jazi M, Dahl H, Zweygberg Wirgart B, Grillner L, Linde A.

Neuropediatrics. 2002 Oct;33(5):266-70.

PMID:
12536370
17.

Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection.

Sjölin H, Tomasello E, Mousavi-Jazi M, Bartolazzi A, Kärre K, Vivier E, Cerboni C.

J Exp Med. 2002 Apr 1;195(7):825-34.

18.

Sequence analysis of UL54 and UL97 genes and evaluation of antiviral susceptibility of human cytomegalovirus isolates obtained from kidney allograft recipients before and after treatment.

Mousavi-Jazi M, Hökeberg I, Schloss L, Zweygberg-Wirgart B, Grillner L, Linde A, Brytting M.

Transpl Infect Dis. 2001 Dec;3(4):195-202.

PMID:
11844151
19.

Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity.

Mousavi-Jazi M, Schloss L, Drew WL, Linde A, Miner RC, Harmenberg J, Wahren B, Brytting M.

J Clin Virol. 2001 Dec;23(1-2):1-15.

PMID:
11595579
20.

Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity.

Cerboni C, Mousavi-Jazi M, Wakiguchi H, Carbone E, Kärre K, Söderström K.

Eur J Immunol. 2001 Oct;31(10):2926-35.

PMID:
11592068
21.

Growth phenotypes of cytomegalovirus isolates do not correlate with glycoprotein B, major immediate early genotypes or antiviral sensitivity.

Mousavi-Jazi M, Sundqvist VA, Linde A, Wahren B, Brytting M.

J Med Virol. 2000 Oct;62(2):117-26.

PMID:
11002239
22.

Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts.

Cerboni C, Mousavi-Jazi M, Linde A, Söderström K, Brytting M, Wahren B, Kärre K, Carbone E.

J Immunol. 2000 May 1;164(9):4775-82.

23.

Free thiol groups are essential for infectivity of human cytomegalovirus.

Mirazimi A, Mousavi-Jazi M, Sundqvist VA, Svensson L.

J Gen Virol. 1999 Nov;80 ( Pt 11):2861-5.

PMID:
10580047
24.

Reactivation of human herpesvirus 6 during pregnancy.

Dahl H, Fjaertoft G, Norsted T, Wang FZ, Mousavi-Jazi M, Linde A.

J Infect Dis. 1999 Dec;180(6):2035-8.

PMID:
10558965
25.

Infrequent detection of cytomegalovirus and Epstein-Barr virus DNA in synovial membrane of patients with rheumatoid arthritis.

Mousavi-Jazi M, Boström L, Lövmark C, Linde A, Brytting M, Sundqvist VA.

J Rheumatol. 1998 Apr;25(4):623-8.

PMID:
9558160
26.

Cytomegalovirus DNA in peripheral blood leukocytes and plasma from bone marrow transplant recipients.

Brytting M, Mousavi-Jazi M, Boström L, Larsson M, Lunderberg J, Ljungman P, Ringdén O, Sundqvist VA.

Transplantation. 1995 Nov 15;60(9):961-5.

PMID:
7491701
27.

PCR detection of CMV DNA in peripheral blood leucocytes and plasma from BMT recipients.

Boström L, Brytting M, Mousavi-Jazi M, Ringden O, Ljungman P, Lönnqvist B, Wahren B, Sundqvist VA.

Transplant Proc. 1994 Jun;26(3):1723-4. No abstract available.

PMID:
8030102

Supplemental Content

Loading ...
Support Center